The Regulation of Inflammatory Mediators in Acute Kidney Injury via Exogenous Mesenchymal Stem Cells

Abstract EN

Acute kidney injury (AKI) remains to be an independent risk factor for mortality and morbidity.

Inflammation is believed to play a major role in the pathophysiology of AKI.

Exogenous mesenchymal stem cells (MSCs) are now under extensive investigation as a potential therapy for AKI.

Various preclinical studies indicated the beneficial effects of MSCs in alleviating renal injury and accelerating tissue repair.

However the mechanisms responsible for these effects are incompletely understood.

In the recent years, anti-inflammatory/immunoregulatory properties of MSCs have become one of the important issues in the treatment of AKI.

This review will summarize the current literature on the regulation of inflammatory mediators via exogenous MSCs contributing to the recovery from AKI.